My daughter has 2 mutations that are being targeted by drugs in clinical trials (G551D -- VX770 and W1282X -- Ataluren). I am trying to be optimistic that these drugs will work well and there might be good treatments for her in the future. I was wondering how optimistic everyone is about these new drugs? Has anyone been in a clinical trial for VX770 or is anyone enrolling their child in the new trial?